Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agents
Helen M. Coley, Christine F. Shotton, Abi Ajose-Adeogun, Helmout Modjtahedi, Hilary ThomasVolume:
72
Year:
2006
Language:
english
Pages:
8
DOI:
10.1016/j.bcp.2006.07.022
File:
PDF, 390 KB
english, 2006